{"nctId":"NCT05780281","briefTitle":"VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)","startDateStruct":{"date":"2020-12-16","type":"ACTUAL"},"conditions":["COVID-19"],"count":367,"armGroups":[{"label":"VIR-7831 plus SOC","type":"EXPERIMENTAL","interventionNames":["Biological: VIR-7831","Biological: Remdesivir"]},{"label":"Placebo plus SOC","type":"PLACEBO_COMPARATOR","interventionNames":["Biological: Placebo","Biological: Remdesivir"]}],"interventions":[{"name":"VIR-7831","otherNames":[]},{"name":"Placebo","otherNames":[]},{"name":"Remdesivir","otherNames":["Veklury"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria: Refer to the master protocol (NCT04501978)\n\nExclusion Criteria: Refer to the master protocol (NCT04501978)\n\nAdditional Exclusion Criteria:\n\n1. Pregnant women\n2. Nursing mothers\n\nIn addition, prior to the initial futility assessment which is performed when approximately 150 participants have been enrolled on VIR-7831 and 150 on placebo, patients on highflow oxygen or non-invasive ventilation (category 5 of the pulmonary ordinal outcome) will be excluded. These patients may be eligible for the trial if the initial futility assessment is passed by this agent.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Sustained Recovery","description":"Sustained recovery defined as being discharged from the index hospitalization, followed by being alive and home for 14 consecutive days prior to Day 90.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"160","spread":null},{"groupId":"OG001","value":"151","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With an Ordinal Outcome on Day 5","description":"Ordinal outcome with 7 mutually exclusive categories","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"14","spread":null}]},{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"20","spread":null}]},{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"42","spread":null}]},{"measurements":[{"groupId":"OG000","value":"66","spread":null},{"groupId":"OG001","value":"58","spread":null}]},{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"40","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Died From All Causes","description":"All-cause mortality","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"13","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With a Safety Outcome Through Day 5","description":"Death, SAE, clinical organ failure, serious infections, or Grade 3 or 4 event through Day 5","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36","spread":null},{"groupId":"OG001","value":"44","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With a Safety Outcome Through Day 28","description":"Death, SAE, clinical organ failure, serious infections, or Grade 3 or 4 event through Day 28","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"51","spread":null},{"groupId":"OG001","value":"58","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With a Safety Outcome Through Day 90","description":"Death, SAE, clinical organ failure, serious infections through Day 90","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"48","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":10,"n":182},"commonTop":["Dyspnea","Hypoxia","Fatigue","Hypotension","Mental status changes"]}}}